Shana Kelley

Yeah, well, I really appreciate, Eric, the way you summed it up.

It's something we're very excited about too.

And you're right that this all started with glucose sensing, right?

It used to be if you were a diabetic, you had to go to the pharmacy to get your glucose measured.

And then you got a handheld, right?

And that really transformed diabetes management.

Now we have continuous glucose monitors that sit on the arm and can read glucose in real time.

But at the core of that is a sensor.

right, that reads out the glucose concentration.

And what's been very elusive when it comes to kind of all other analytes, especially protein analytes, is how to get that same form factor, you know, how to have an autonomous sensor that can just sit in a fluid in the human body and read out concentrations.

And so that's the problem we've been working away on for several years, many years.

And we eventually came up with a sensor that's basically like a molecular motion detector.

It sits on the surface of an electrode and it's just kind of it's moving around.

We use electric fields to kind of move it in a way that we can monitor.

And it turns out that when the sensor binds a protein of interest.

That slows it down.

And so we can just watch that motion, do that over time, and quantitate concentrations of proteins in the blood or in the interstitial fluid is usually where we're making our measurements.

Yeah, that's exactly right.

So I have a puppy at home and we throw balls for him all the time.

He's really good.